Disc Medicine, Inc. (IRON)
75.14
-0.97
(-1.27%)
USD |
NASDAQ |
Nov 20, 16:00
75.16
+0.02
(+0.03%)
After-Hours: 20:00
Disc Medicine Shareholders Equity (Quarterly) : 604.25M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 604.25M |
| June 30, 2026 | 644.16M |
| March 31, 2026 | 688.43M |
| December 31, 2025 | 739.83M |
| September 30, 2025 | 573.39M |
| June 30, 2025 | 614.16M |
| March 31, 2025 | 660.36M |
| December 31, 2024 | 443.59M |
| September 30, 2024 | 467.96M |
| June 30, 2024 | 488.83M |
| March 31, 2024 | 338.07M |
| December 31, 2023 | 345.12M |
| September 30, 2023 | 358.97M |
| Date | Value |
|---|---|
| June 30, 2023 | 371.22M |
| March 31, 2023 | 232.86M |
| December 31, 2022 | 176.60M |
| September 30, 2022 | 104.57M |
| June 30, 2022 | 106.90M |
| March 31, 2022 | 111.61M |
| December 31, 2021 | 77.65M |
| September 30, 2021 | 140.86M |
| June 30, 2021 | 157.68M |
| March 31, 2021 | 171.16M |
| December 31, 2020 | -21.86M |
| September 30, 2020 | 117.58M |
| June 30, 2020 | 0.0235M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -105.37M |
| Amgen, Inc. | 14.35B |
| Anika Therapeutics, Inc. | 137.58M |
| BioCryst Pharmaceuticals, Inc. | -397.38M |
| Imunon, Inc. | 2.622M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 699.49M |
| Total Liabilities (Quarterly) | 95.24M |
| Debt to Equity Ratio | 0.1011 |
| Current Ratio | 20.30 |
| Net Debt Paydown Yield | -0.24% |